Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
UroMedical Stockholm AB
AB
Active
Org 5591183149
Drottninggatan 97, 113 60
Stockholm
Medical specialists activities
·
NACE 8622
Est. 2017 · 9 years old
24 employees
Monitor
Share
Sweden
/
Companies
/
Medical specialists activities
/
UroMedical Stockholm AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
92M
69M
46M
23M
0M
2021: 34M
34M
2021
2022: 29M (-15% vs 2021)
29M
-15%
2022
2023: 43M (+48% vs 2022)
43M
+48%
2023
2024: 54M (+26% vs 2023)
54M
+26%
2024
2025: 74M (+37% vs 2024)
74M
+37%
2025
EBITDA
SEK millions
8M
3M
-2M
-6M
-11M
2021: 4M
4M
2021
2022: -7M (-275% vs 2021)
-7M
-275%
2022
2023: 1M (+114% vs 2022)
1M
+114%
2023
2024: -4M (-500% vs 2023)
-4M
-500%
2024
2025: -5M (-25% vs 2024)
-5M
-25%
2025
Income statement
SEK thousands
Item
2025
2024
2023
2022
2021
Revenue
73 859
54 093
42 789
29 245
33 939
Staff expenses
−28 978
−21 406
−15 154
−12 082
—
EBITDA
−4 731
−3 740
1 229
−6 643
3 843
Depreciation & amort.
−1 514
−688
−525
−1 607
−1 558
EBIT
−6 244
−4 429
703
−8 250
2 285
Net financials
−423
−11 850
16
−88
−2
Profit before tax
0
−13 089
0
1 341
1 256
Tax
—
—
—
−302
−269
Net profit
0
−13 089
0
1 038
987
Balance sheet
SEK thousands
Item
2025
2024
2023
2022
2021
Total assets
27 646
17 024
18 116
14 991
13 860
Equity
7 648
2 148
7 537
7 537
6 499
Long-term debt
546
—
—
—
0
Short-term debt
19 452
14 877
6 009
4 265
2 844
Total debt
19 999
14 877
6 009
4 265
2 844
Financial ratios
5-year trend
EBITDA margin
−6,4 %
This company
15,8 %
Market median
This company
Market median
141% below market
2021
2025
Equity ratio
27,7 %
This company
38,2 %
Market median
This company
Market median
27% below market
2021
2025
Return on equity
0,0 %
This company
18,4 %
Market median
This company
Market median
100% below market
2021
2025
Net profit margin
0,0 %
This company
8,1 %
Market median
This company
Market median
100% below market
2021
2025
Asset turnover
2,67×
This company
1,12×
Market median
This company
Market median
138% above market
2021
2025
Debt / equity
2,62×
This company
0,62×
Market median
This company
Market median
323% above market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
More on UroMedical Stockholm AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
